ArticleNeuro-oncology practice2025

Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023.

Vincent Fougner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.